動物用ワクチン市場：製品タイプ別-2025～2030年の世界予測

動物用ワクチン市場は、2023年に163億9,000万米ドルと評価され、2024年には177億5,000万米ドルに達すると予測され、CAGR 8.34％で成長し、2030年には287億2,000万米ドルに達すると予測されています。

動物用ワクチン市場には、家畜、家畜、野生動物の疾病を予防・制御するために開発された様々な免疫学的製品が含まれます。これらのワクチンは、動物の健康を守り、農業生産性を向上させ、人獣共通感染症のヒトへのトランスミッションを減少させるために極めて重要です。その用途は、ペットへの定期的な予防接種から、牛、家禽、豚などの家畜への大規模な接種まで幅広く、特定のエンドユーザーは動物病院、クリニック、農場、研究機関などです。市場成長の原動力となっているのは、ペットの飼育数の増加、動物由来の食品の消費量の増加、動物の健康に対する意識の高まりです。さらに、人獣共通感染症の発生に対する世界の懸念の高まりは、厳格なワクチン接種プログラムの重要性を浮き彫りにしています。組換えDNAワクチンやナノ粒子ベースの送達システムなどの技術的進歩は、技術革新の大きな機会をもたらしています。企業は研究開発に投資することで、こうした進歩を活用し、より少ない投与量でより広い予防効果を提供するワクチンを開発することができます。しかし、市場開拓は、厳しい規制の枠組み、高い開発コスト、新興国におけるワクチンの保管や流通の問題など、いくつかの課題に直面しています。政府機関と提携し、承認プロセスを合理化するためにAI主導の分析を活用することで、こうした障壁に対処することで、市場浸透を強化することができます。また、複数の病原体に対する交差防御を提供するワクチンの開発や、コンプライアンスと投与しやすさを改善するための経口・経鼻投与法の探求にも機会があります。個別化獣医医療とデータ分析に注力することで、地域の疾病流行と動物の人口統計に基づいてオーダーメイドのワクチン接種プログラムを提供し、市場の成長を促進することができます。競合を維持するために、企業は技術革新、戦略的提携、新興市場への進出を優先し、ワクチン接種の利点に関する認識を高めるための教育的取り組みも行うべきです。まとめると、動物用ワクチン市場は、技術の進歩と動物の健康重視の高まりに牽引され、持続的な成長を遂げる態勢にあるが、ポテンシャルを最大限に引き出すためには、さまざまな規制や物流のハードルを乗り越えなければならないです。

市場力学：急速に進化する動物用ワクチン市場の主要市場洞察を公開

動物用ワクチン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 家畜人口の増加
  • 畜産物の商業化に伴う畜産の増加
  • 人獣共通感染症の増加
• 市場抑制要因
  • 供給コストは比較的高く、資本収益率はヒト用ワクチンより低い
• 市場機会
  • 生ワクチンからDNAワクチンへのシフト
  • ワクチンの継続的な技術進歩
• 市場課題
  • ワクチンの悪影響

ポーターのファイブフォース：動物用ワクチン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用ワクチン市場における外部からの影響の把握

外部マクロ環境要因は、動物用ワクチン市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：動物用ワクチン市場における競合情勢の把握

動物用ワクチン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：動物用ワクチン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用ワクチン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：動物用ワクチン市場における成功への道筋を描く

動物用ワクチン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品上市、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 家畜の増加
    • 畜産業の発展と畜産物の商業化
    • 人獣共通感染症の発生率増加
  • 抑制要因
    • 供給コストは比較的高く、ヒト用ワクチンよりも資本収益率が低い
  • 機会
    • 生弱毒化ワクチンからDNAワクチンへの移行
    • ワクチンの継続的な技術進歩
  • 課題
    • ワクチンの副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 動物用ワクチン市場：製品別

• イントロダクション
• 弱毒生ワクチン
• DNAワクチン
• 不活化ワクチン
• 組み換えワクチン
• サブユニットワクチン

第7章 動物用ワクチン市場：動物タイプ別

• イントロダクション
• 水生動物
  • エロモナス
  • 連鎖球菌症
  • ビブリオ
• コンパニオン
  • イヌ
    • 犬のヘルペス
    • ジステンパー
    • ケンネルコフ
    • ライム病
    • パルボウイルス
    • 狂犬病犬
  • ネコ
    • カリシウイルス
    • コロナウイルス猫
    • 汎白血球減少症
    • 狂犬病猫
    • 鼻気管炎
• 家禽
  • 鳥インフルエンザ
  • 感染性気管支炎
  • マレック病
  • ニューカッスル病
  • サルモネラ
• 反芻動物
  • コロナウイルス反芻動物
  • 大腸菌
  • 口蹄疫（FMD）
  • ランピースキン病
  • ロタウイルス

第8章 南北アメリカの動物用ワクチン市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の動物用ワクチン市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの動物用ワクチン市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Anicon Labor GmbH by SAN Group
• Biogenesis Bago S.A.
• Boehringer Ingelheim International GmbH
• Brilliant Bio Pharma Private limited
• Ceva Sante Animale
• China Animal Husbandry Industry Co., Ltd.
• Dalan Animal Health.
• Eli Lilly and Company
• Endovac Animal Health, LLC
• Heska Corporation
• Hester Biosciences Limited
• HIPRA, S.A.
• Indian Immunologicals Limited
• Merck KGaA
• Neogen Corporation
• Pfizer Inc.
• Phibro Animal Health Corporation
• Sanofi S.A.
• Torigen Pharmaceuticals Inc.
• Vaxxinova GmbH
• VEROVACCiNES GmbH
• Vetigenics
• Vetoquinol SA
• Virbac, Inc.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. ANIMAL VACCINES MARKET RESEARCH PROCESS
• FIGURE 2. ANIMAL VACCINES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANIMAL VACCINES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANIMAL VACCINES MARKET DYNAMICS
• TABLE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES CANINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS FELINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES FELINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 75. CANADA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. CANADA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 77. CANADA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 78. CANADA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 79. CANADA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 80. CANADA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 81. CANADA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 82. CANADA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 117. CHINA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. CHINA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 119. CHINA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 120. CHINA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 121. CHINA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 122. CHINA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 123. CHINA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 124. CHINA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 125. INDIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. INDIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 127. INDIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 128. INDIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 129. INDIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 130. INDIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 131. INDIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 132. INDIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 133. INDONESIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. INDONESIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 135. INDONESIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 136. INDONESIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 138. INDONESIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 140. INDONESIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 141. JAPAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. JAPAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 143. JAPAN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 144. JAPAN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 145. JAPAN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 147. JAPAN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 148. JAPAN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 149. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 151. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 152. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 153. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 154. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 156. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 157. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 159. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 160. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 161. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 162. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 163. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 164. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 165. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 168. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 169. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 170. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 171. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 172. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 176. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 177. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 178. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 179. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 180. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 181. TAIWAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. TAIWAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 183. TAIWAN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 184. TAIWAN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 185. TAIWAN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 186. TAIWAN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 187. TAIWAN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 188. TAIWAN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 189. THAILAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. THAILAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 191. THAILAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 192. THAILAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 193. THAILAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 194. THAILAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 195. THAILAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 196. THAILAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 197. VIETNAM ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. VIETNAM ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 199. VIETNAM ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 200. VIETNAM ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 201. VIETNAM ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 202. VIETNAM ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 203. VIETNAM ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 204. VIETNAM ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 214. DENMARK ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. DENMARK ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 216. DENMARK ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 217. DENMARK ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 218. DENMARK ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 219. DENMARK ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 220. DENMARK ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 221. DENMARK ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 222. EGYPT ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. EGYPT ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 224. EGYPT ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 225. EGYPT ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 226. EGYPT ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 227. EGYPT ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 228. EGYPT ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 229. EGYPT ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 230. FINLAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 231. FINLAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 232. FINLAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 233. FINLAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 234. FINLAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 235. FINLAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 236. FINLAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 237. FINLAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 238. FRANCE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 239. FRANCE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 240. FRANCE ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 241. FRANCE ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 242. FRANCE ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 243. FRANCE ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 244. FRANCE ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 245. FRANCE ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 246. GERMANY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. GERMANY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 248. GERMANY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 249. GERMANY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 250. GERMANY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 251. GERMANY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 252. GERMANY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 253. GERMANY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 254. ISRAEL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 255. ISRAEL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 256. ISRAEL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 257. ISRAEL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 258. ISRAEL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 259. ISRAEL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 260. ISRAEL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 261. ISRAEL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 262. ITALY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 263. ITALY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 264. ITALY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 265. ITALY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 266. ITALY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 267. ITALY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 268. ITALY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 269. ITALY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 270. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 271. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 272. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 273. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 274. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 275. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 276. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 277. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 278. NIGERIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 279. NIGERIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 280. NIGERIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 281. NIGERIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 282. NIGERIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 283. NIGERIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 284. NIGERIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 285. NIGERIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 286. NORWAY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 287. NORWAY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 288. NORWAY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 289. NORWAY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 290. NORWAY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 291. NORWAY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 292. NORWAY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 293. NORWAY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 294. POLAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 295. POLAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 296. POLAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 297. POLAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 298. POLAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 299. POLAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 300. POLAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 301. POLAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 302. QATAR ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 303. QATAR ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 304. QATAR ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 305. QATAR ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 306. QATAR ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 307. QATAR ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 308. QATAR ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 309. QATAR ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 310. RUSSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 311. RUSSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 312. RUSSIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 313. RUSSIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 314. RUSSIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 315. RUSSIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 316. RUSSIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 317. RUSSIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 318. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 319. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 320. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 321. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 322. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 323. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 324. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 325. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 326. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 327. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 328. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 329. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 330. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 331. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 332. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 333. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 334. SPAIN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 335. SPAIN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 336. SPAIN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 337. SPAIN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 338. SPAIN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 339. SPAIN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 340. SPAIN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 341. SPAIN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 342. SWEDEN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 343. SWEDEN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 344. SWEDEN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 345. SWEDEN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 346. SWEDEN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 347. SWEDEN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 348. SWEDEN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 349. SWEDEN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 350. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 351. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 352. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 353. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 354. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 355. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 356. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 357. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 358. TURKEY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 359. TURKEY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 360. TURKEY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 361. TURKEY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 362. TURKEY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 363. TURKEY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 364. TURKEY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 365. TURKEY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 366. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 367. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 368. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 369. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 370. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 371. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
• TABLE 372. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
• TABLE 373. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
• TABLE 374. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 375. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 376. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
• TABLE 377. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
• TABLE 378. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
• TABLE 379. UNITED KINGDOM ANIMAL V

The Animal Vaccines Market was valued at USD 16.39 billion in 2023, expected to reach USD 17.75 billion in 2024, and is projected to grow at a CAGR of 8.34%, to USD 28.72 billion by 2030.

The animal vaccines market encompasses various immunological products developed to prevent and control diseases in domesticated animals, livestock, and wildlife. These vaccines are crucial for safeguarding animal health, improving agricultural productivity, and reducing the transmission of zoonotic diseases to humans. Their applications range from routine immunizations in pets to large-scale inoculations in livestock like cattle, poultry, and pigs, with specific end-users comprising veterinary hospitals, clinics, farms, and research institutions. Market growth is fueled by rising pet ownership, increased consumption of animal-derived food products, and heightened awareness of animal health. Moreover, growing global concerns about zoonotic disease outbreaks have highlighted the significance of rigorous vaccination programs. Technological advancements, such as recombinant DNA vaccines and nanoparticle-based delivery systems, present vast opportunities for innovation. Companies can leverage these advancements by investing in R&D to develop vaccines offering broader protection with fewer doses. However, market expansion faces several challenges, including stringent regulatory frameworks, high development costs, and vaccine storage and distribution issues in developing regions. Addressing these barriers by partnering with government agencies and harnessing AI-driven analytics for streamlined approval processes can enhance market penetration. Opportunities also lie in developing vaccines that provide cross-protection against multiple pathogens, as well as exploring oral and intranasal delivery methods to improve compliance and ease of administration. Focusing on personalized veterinary medicine and data analytics can provide tailored vaccination programs based on regional disease prevalence and animal demographics, fostering market growth. To remain competitive, companies should prioritize technological innovation, strategic alliances, and expansion into emerging markets, coupled with educational initiatives to raise awareness about the benefits of vaccination. In summary, the animal vaccines market is poised for sustained growth, driven by technological advancements and a growing emphasis on animal health, though it must navigate various regulatory and logistical hurdles to maximize potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Vaccines Market

The Animal Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing Livestock Population
  • Rising Animal Husbandry along with Commercialization of Animal Products
  • Increasing Incidences of Zoonotic Diseases
• Market Restraints
  • Supply End Costs are Relatively High, with Poorer Capital Returns than Human Vaccines
• Market Opportunities
  • Shift from Live Attenuated Vaccines to DNA Vaccines
  • Continuous Technological Advancements in Vaccines
• Market Challenges
  • Adverse Impacts of Vaccines

Porter's Five Forces: A Strategic Tool for Navigating the Animal Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Vaccines Market

A detailed market share analysis in the Animal Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Vaccines Market

A strategic analysis of the Animal Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Vaccines Market, highlighting leading vendors and their innovative profiles. These include Anicon Labor GmbH by SAN Group, Biogenesis Bago S.A., Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd., Dalan Animal Health., Eli Lilly and Company, Endovac Animal Health, LLC, Heska Corporation, Hester Biosciences Limited, HIPRA, S.A., Indian Immunologicals Limited, Merck KGaA, Neogen Corporation, Pfizer Inc., Phibro Animal Health Corporation, Sanofi S.A., Torigen Pharmaceuticals Inc., Vaxxinova GmbH, VEROVACCiNES GmbH, Vetigenics, Vetoquinol SA, Virbac, Inc., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Subunit Vaccines.
• Based on Animal Type, market is studied across Aqua, Companion, Poultry, and Ruminants. The Aqua is further studied across Aeromonas, Streptococcosis, and Vibrio. The Companion is further studied across Canine and Feline. The Canine is further studied across Canine Herpes, Distemper, Kennel Cough, Lyme Disease, Parvovirus, and Rabies Canine. The Feline is further studied across Calicivirus, Coronavirus Feline, Panleukopenia, Rabies Feline, and Rhinotracheitis. The Poultry is further studied across Avian Influenza, Infectious Bronchitis, Marek's Disease, Newcastle Disease, and Salmonella. The Ruminants is further studied across Coronavirus Ruminants, E. Coli, Foot & mouth disease (FMD), Lumpy skin, and Rotavirus.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Livestock Population
    • 5.1.1.2. Rising Animal Husbandry along with Commercialization of Animal Products
    • 5.1.1.3. Increasing Incidences of Zoonotic Diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Supply End Costs are Relatively High, with Poorer Capital Returns than Human Vaccines
  • 5.1.3. Opportunities
    • 5.1.3.1. Shift from Live Attenuated Vaccines to DNA Vaccines
    • 5.1.3.2. Continuous Technological Advancements in Vaccines
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse Impacts of Vaccines
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Animal Vaccines Market, by Product

• 6.1. Introduction
• 6.2. Attenuated Live Vaccines
• 6.3. DNA Vaccines
• 6.4. Inactivated Vaccines
• 6.5. Recombinant Vaccines
• 6.6. Subunit Vaccines

7. Animal Vaccines Market, by Animal Type

• 7.1. Introduction
• 7.2. Aqua
  • 7.2.1. Aeromonas
  • 7.2.2. Streptococcosis
  • 7.2.3. Vibrio
• 7.3. Companion
  • 7.3.1. Canine
    • 7.3.1.1. Canine Herpes
    • 7.3.1.2. Distemper
    • 7.3.1.3. Kennel Cough
    • 7.3.1.4. Lyme Disease
    • 7.3.1.5. Parvovirus
    • 7.3.1.6. Rabies Canine
  • 7.3.2. Feline
    • 7.3.2.1. Calicivirus
    • 7.3.2.2. Coronavirus Feline
    • 7.3.2.3. Panleukopenia
    • 7.3.2.4. Rabies Feline
    • 7.3.2.5. Rhinotracheitis
• 7.4. Poultry
  • 7.4.1. Avian Influenza
  • 7.4.2. Infectious Bronchitis
  • 7.4.3. Marek's Disease
  • 7.4.4. Newcastle Disease
  • 7.4.5. Salmonella
• 7.5. Ruminants
  • 7.5.1. Coronavirus Ruminants
  • 7.5.2. E. Coli
  • 7.5.3. Foot & mouth disease (FMD)
  • 7.5.4. Lumpy skin
  • 7.5.5. Rotavirus

8. Americas Animal Vaccines Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Animal Vaccines Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Animal Vaccines Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Anicon Labor GmbH by SAN Group
• 2. Biogenesis Bago S.A.
• 3. Boehringer Ingelheim International GmbH
• 4. Brilliant Bio Pharma Private limited
• 5. Ceva Sante Animale
• 6. China Animal Husbandry Industry Co., Ltd.
• 7. Dalan Animal Health.
• 8. Eli Lilly and Company
• 9. Endovac Animal Health, LLC
• 10. Heska Corporation
• 11. Hester Biosciences Limited
• 12. HIPRA, S.A.
• 13. Indian Immunologicals Limited
• 14. Merck KGaA
• 15. Neogen Corporation
• 16. Pfizer Inc.
• 17. Phibro Animal Health Corporation
• 18. Sanofi S.A.
• 19. Torigen Pharmaceuticals Inc.
• 20. Vaxxinova GmbH
• 21. VEROVACCiNES GmbH
• 22. Vetigenics
• 23. Vetoquinol SA
• 24. Virbac, Inc.
• 25. Zoetis Inc.